相关实验视频
Updated: Jun 22, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
897
循环性血小板缺血的高低
Haiyu Zhang1, Alejandro Villar-Prados2, James B Bussel3
1Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
British journal of haematology
|December 12, 2023
概括
循环血小板缺血症 (CTP) 涉及定期的血小板计数波动. 本综述探讨了CTP的病理生理学,确定了基因变异和骨髓增殖性疾病作为其发展的关键因素.
科学领域:
- 血液学 血液学 血液学
- 病理生理学 病理生理学
- 遗传学 是一个遗传学.
背景情况:
- 循环血小板缺血症 (CTP) 是通过显著的,定期的血小板计数波动来定义的.
- CTP经常被误诊为免疫血小板缺血症,导致不有效的治疗方法.
- 在骨髓增殖性疾病的基尿素疗法中,CTP也可以表现出来.
研究的目的:
- 为了解循环血小板衰竭的病理生理学提供一个框架.
- 探索与CTP相关的历史,理论和临床发现.
- 确定导致CTP的致病因素.
主要方法:
- 对CTP的历史,理论和临床数据的审查.
- 对血小板和血小板蛋白振荡模式的分析.
- 评估基因变异及其在CTP中的作用.
主要成果:
- CTP涉及固有的血小板/血小板蛋白振荡和稳定的周期性.
- 病原性因素破坏了血小板平衡的稳定,使得血小板的振荡变得过度.
- 有关的是遗传变异 (MPL,STAT3,DNMT3A) 和骨髓增殖性疾病驱动因素 (JAK2 V617F,BCR::ABL1).
结论:
- 了解CTP的病理生理学需要认识到内在的振荡机制和破坏稳定的致病因素.
- 遗传变异和潜在的血液状况对于CTP发展至关重要.
- 阐明CTP病原性为向治疗开辟了道路.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

